by mpzzqmvj | Oct 19, 2021 | Press Releases
Company engaged in ongoing initiatives to help raise awareness and provide information on research and support for patients and families GAINESVILLE, Fla. – Cyclo Therapeutics, Inc. (Nasdaq: CYTH), a clinical stage biotechnology company dedicated to developing...
by mpzzqmvj | Oct 18, 2021 | Press Releases
GAINESVILLE, Fla. – Cyclo Therapeutics, Inc. (Nasdaq: CYTH) (“Cyclo Therapeutics” or the “Company”), a clinical stage biotechnology company dedicated to developing life-changing medicines through science and innovation for patients and...
by mpzzqmvj | Oct 6, 2021 | Press Releases
Sharon H. Hrynkow, PhD, Chief Scientific Officer, Senior Vice President of Medical Affairs to participate in a Moderated round-table discussion with academics and industrial experts on October 11, 2021 at 4:30 PM (CET) / 10:30 AM (EST) GAINESVILLE, Fla. – Cyclo...
by mpzzqmvj | Sep 27, 2021 | Press Releases
– Dr. Kjems is a leading global physician scientist with a proven pharma track record of drug development across multiple therapeutic areas, including chronic indications, oncology and rare diseases – – Gerald F. Cox, MD, PhD will continue offering...
by mpzzqmvj | Sep 15, 2021 | Press Releases
– Live webcast presentation on Wednesday, September 22nd at 10:45 AM ET GAINESVILLE, Fla. – Cyclo Therapeutics, Inc. (Nasdaq: CYTH) (“Cyclo Therapeutics” or the “Company”), a clinical stage biotechnology company dedicated to...
